November 18, 2026 · Facial plastic surgery & aesthetic medicine · DOI: 10.1177/26893614261504663

Is It Safe to Treat Patients with Botulinum Toxin A During the Peri-Conception Period of Pregnancy? A Systematic Review of the Literature.

Listen to this summary

This systematic review asked whether botulinum toxin A injections during the peri-conception period (3 months before through after conception) are associated with adverse maternal or fetal outcomes, such as miscarriage, preterm labor, or congenital anomalies, relative to the general U.S. obstetric population. Across 10 eligible studies (mostly case reports and series) covering 143 pregnancies, miscarriage occurred in 3% of pregnancies, with isolated reports of one preterm labor case with a fetal renal anomaly and one case of fetal growth restriction. The authors concluded that exposure was not associated with increased adverse outcomes compared with population rates, but noted that the small, heterogeneous evidence base limits firm conclusions.

Shaghauyegh S Azar, Nika Darvish, Neil N Patel, Arianna G Cassidy, Gaelen B Stanford-Moore

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play